GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Operating Margin %

MeCure Industries (NSA:MECURE) Operating Margin % : 0.00% (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. MeCure Industries's Operating Income for the six months ended in . 20 was ₦0.00 Mil. MeCure Industries's Revenue for the six months ended in . 20 was ₦0.00 Mil. Therefore, MeCure Industries's Operating Margin % for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for MeCure Industries's Operating Margin % or its related term are showing as below:


NSA:MECURE's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.89
* Ranked among companies with meaningful Operating Margin % only.

MeCure Industries's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

MeCure Industries's Operating Income for the six months ended in . 20 was ₦0.00 Mil.


MeCure Industries Operating Margin % Historical Data

The historical data trend for MeCure Industries's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeCure Industries Operating Margin % Chart

MeCure Industries Annual Data
Trend
Operating Margin %

MeCure Industries Semi-Annual Data
Operating Margin %

Competitive Comparison of MeCure Industries's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, MeCure Industries's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeCure Industries's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MeCure Industries's Operating Margin % distribution charts can be found below:

* The bar in red indicates where MeCure Industries's Operating Margin % falls into.


;
;

MeCure Industries Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

MeCure Industries's Operating Margin % for the fiscal year that ended in . 20 is calculated as

Operating Margin %=Operating Income (A: . 20 ) / Revenue (A: . 20 )
= /
= %

MeCure Industries's Operating Margin % for the quarter that ended in . 20 is calculated as

Operating Margin %=Operating Income (Q: . 20 ) / Revenue (Q: . 20 )
= /
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MeCure Industries  (NSA:MECURE) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


MeCure Industries Operating Margin % Related Terms

Thank you for viewing the detailed overview of MeCure Industries's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MeCure Industries Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA
MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines